The NCCN Oncology Policy Program was initiated in 2009 to allow opportunities for discussion among oncology stakeholders to address relevant health policy concerns. The NCCN Oncology Policy Program has convened Policy Summits in areas such as comparative effectiveness research (CER), risk evaluation and mitigation strategies (REMS), patient advocacy, off-label drug use and compendia, biosimilars, molecular testing, clinical pathways, and data needs.
NCCN will continue this initiative in 2013 with invitation-only summits focused on current policy topics. Details on NCCN's 2013 policy programs, as well as past summits, can be found below.
Please send any comments or questions regarding the NCCN Oncology Policy Program to email@example.com.
Patient Advocacy: Patient Perspectives Across the Cancer Care Continuum, November 2012
Data Needs in Oncology – Clinical, Regulatory, Coverage, and Policy Issues, October 2012
Equity in Cancer Care: Pathways, Protocols, and Guidelines, May 2012